Home | Welcome to Contract Pharma   
Last Updated Monday, June 1 2015

Print

Search Results for 'Financial Reports'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 18, 2015
Pharma sales down 9% in the quarter Read More »
Published May 18, 2015
Pharma sales down 7% in the quarter Read More »
Published May 14, 2015
Biologics Services revenues up 75% in the quarter Read More »
Published May 7, 2015
Service revenue up 7% in the quarter Read More »
Published May 6, 2015
Oral Technologies drive growth in the quarter Read More »
Published May 5, 2015
Contract revenue up 47% in the quarter Read More »
Published May 5, 2015
Revenues up 72% in the quarter Read More »
Published April 30, 2015
Genzyme sales up 31% in the quarter Read More »
Published April 30, 2015
Revenues up 24% in the quarter Read More »
Published April 30, 2015
Exchange rates impact earnings Read More »
Published April 30, 2015
Currency translation impacts results by 10% Read More »
Published April 30, 2015
Early Discovery acquisitions contribute to growth Read More »
Published April 30, 2015
Integrated Healthcare Services revenues up 20% Read More »
Published April 28, 2015
Service revenues up 15% Read More »
Published April 28, 2015
Revenues up 11% in the quarter Read More »
Published April 28, 2015
Foreign exchange and Consumer Care divestiture impact results Read More »
Published April 28, 2015
Established product sales drop 10% Read More »
Published April 28, 2015
Eliquis sales soar to $355 million Read More »
Published April 28, 2015
Specialty Injectable Pharmaceuticals up 13% Read More »
Published April 24, 2015
Animal Health offsets lingering effects of patent expirations for Cymbalta and Evista Read More »
Published April 24, 2015
Soliris sales up 6% Read More »
Published April 24, 2015
BioScience business revenues up 2% Read More »
Published April 24, 2015
TECFIDERA revenues up 63% Read More »
Published April 24, 2015
Product sales were up 13% in the quarter Read More »
Published March 10, 2015
Achieves 10% growth Read More »
Published March 6, 2015
Manufacturing revenue up 33% in the quarter Read More »
Published March 3, 2015
EpiPen drives Specialty segment sales up 38% Read More »
Published February 25, 2015
Revenues up 13% in the quarter Read More »
Published February 24, 2015
Revenues up 29% in the quarter Read More »
Published February 23, 2015
Dermatology sales were up 70% in the quarter Read More »
Published February 19, 2015
Revenues up 2% in the quarter Read More »
Published February 18, 2015
North American Brands business up 188% in the quarter Read More »
Published February 12, 2015
Contract revenue up 35% in the quarter Read More »
Published February 12, 2015
U.S. Specialty Injectable segment drives growth in the quarter Read More »
Published February 12, 2015
Product Development business drives growth in the quarter Read More »
Published February 12, 2015
Medication Delivery segment drives growth in the quarter Read More »
Published February 11, 2015
EYLEA sales up 39% in the quarter Read More »
Published February 11, 2015
Discovery and manufacturing services drive growth Read More »
Published February 9, 2015
Revenues up 56% in the quarter driven by Captisol Read More »
Published February 5, 2015
Respiratory and vaccine declines impact results Read More »
Published February 5, 2015
Specialty pharma sales up 12% in the quarter Read More »
Published February 5, 2015
Generic sales slide under European business strategy Read More »
Published February 5, 2015
Revenues up 7% in the quarter Read More »
Published February 4, 2015
Patent expiries and divestitures impact results Read More »
Published February 4, 2015
Sovaldi sales drive record growth Read More »
Published January 30, 2015
MS portfolio drives growth Read More »
Published January 30, 2015
U.S. patent expirations hurt results Read More »
Published January 30, 2015
HUMIRA sales up 11% in the quarter Read More »
Published January 29, 2015
Clinical Research Services revenue up 4% Read More »
Published January 29, 2015
Soliris sales up 44% for the year Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On